A significant breakthrough for the medical field and those suffering from sickle cell disease (SCD) and thalassemia, an innovative gene therapy employing CRISPR/Cas9 technology has exhibited an extrao...
Lung cancer vaccine The 'LungVax' vaccine, developed by researchers from the University of Oxford, the Francis Crick Institute, and University College London, employs technology akin to that of the v...
IntroductionDespite being a minority among T cells, γδ T cells play crucial roles in immune defense against infections and in the suppression of malignancies. T cells have the potential to be a good...
August 2024: Medical professionals have initiated clinical trials for the first-ever mRNA lung cancer vaccine, which has been praised by specialists for its revolutionary ability to potentially rescue...
August 2024: The Food and Drug Administration (FDA) has granted approval for the use of lazertinib (Lazcluze, Janssen Biotech, Inc.) in combination with amivantamab-vmjw (Rybrevant, Janssen Biotech, I...
August 2024: The Food and Drug Administration has granted approval for the use of durvalumab (Imfinzi, AstraZeneca) in combination with platinum-containing chemotherapy as a neoadjuvant treatment, fol...
August 2024: The Food and Drug Administration has granted approval for dostarlimab-gxly (Jemperli, GSK) in combination with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for t...
July 2024: The Food and Drug Administration (FDA) has granted approval for the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Research & Development, LLC) in conjunction with ...
June 2024: The Food and Drug Administration has given accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.), a bispecific CD20-directed CD3 T-cell engager, for adult patients with recurr...
IntroductionBlood cancers, also known as hematologic malignancies, include leukemia, lymphoma, and multiple myeloma. These cancers have their origins in either bone marrow or the lymphatic system an...